Department of Health and Human Services January 9, 2014 – Federal Register Recent Federal Regulation Documents
Results 1 - 6 of 6
Prospective Grant of Exclusive License: The Development of a Veterinary Rabies Vaccine Based on the ERAg3m Virus Strain
This is notice, in accordance with 35 U.S.C. 209 and 37 CFR part 404, that the National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an exclusive license to practice the inventions embodied in U.S. Provisional Patent Application No. 60/727,038, entitled ``Method of Sequencing Whole Viral Genomes, Related Compositions, and Genome Sequences'', filed October 14, 2005 (HHS Ref. No. E-326-2013/0- US-01); PCT Patent Application No. PCT/US2006/040134, entitled ``Rabies Virus Compositions and Methods'', filed October 13, 2006, (E-326-2013/ 0-PCT-02); and Chinese Patent Application No. 200680038314.4, entitled ``Rabies Virus Compositions and Methods'', filed October 13, 2006 (HHS Ref. No. E-326-2013/0-CN-06). The patent rights in these inventions have been assigned to the Government of the United States of America. The prospective exclusive license territory is China, and the field of use may be limited to ``Rabies vaccines based on the ERAg3m virus strain for veterinary use only.''
Government-Owned Inventions; Availability for Licensing
The inventions listed below are owned by an agency of the U.S. Government and are available for licensing in the U.S. in accordance with 35 U.S.C. 209 and 37 CFR part 404 to achieve expeditious commercialization of results of federally-funded research and development. Foreign patent applications are filed on selected inventions to extend market coverage for companies and may also be available for licensing.
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.